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Induced pluripotent stem cells (iPSCs) may represent
an ideal cell source for future regenerative therapies.
A critical issue concerning the clinical use of patient-
specific iPSCs is the accumulation of mutations in
somatic (stem) cells over an organism’s lifetime.
Acquired somatic mutations are passed onto iPSCs
during reprogramming and may be associated with
loss of cellular functions and cancer formation.
Here we report the generation of human iPSCs
from cord blood (CB) as a juvenescent cell source.
CBiPSCs show characteristics typical of embryonic
stem cells and can be differentiated into derivatives
of all three germ layers, including functional cardio-
myocytes. For future therapeutic production of autol-
ogous and allogeneic iPSC derivatives, CB could
be routinely harvested for public and commercial
CB banks without any donor risk. CB could readily
become available for pediatric patients and, in par-
ticular, for newborns with genetic diseases or con-
genital malformations.
INTRODUCTION
Recent evidence indicates that somatic cells can be reprog-
rammed to the pluripotent state by the overexpression of several
transcription factors, including OCT4 (also known as POU5F1),
SOX2, NANOG, MYC, KLF4, and LIN28 (Takahashi et al., 2007;
Yu et al., 2007). Most of the iPSC lines described thus far have
been isolated from skin fibroblasts or other cell types that require
harvesting via surgical interventions. For clinical application, it is
desired to identify alternative reprogrammable cell types that
can be readily collected without invasive procedures.
Blood is a cell source that can be easily obtained from most
patients. However, the reprogramming of predominantly nonad-434 Cell Stem Cell 5, 434–441, October 2, 2009 ª2009 Elsevier Inc.herent and slow-cycling human peripheral blood cell types has
been unsuccessful to date. A very recent report described the
successful reprogramming of human CD34+ hematopoietic
stem cells (Loh et al., 2009), but these cells were isolated from
peripheral blood by previous G-CSF mobilization, a procedure
that is frequently associated with side effects, including bone
pain, headache, fatigue, and nausea (Cashen et al., 2007). In
addition, more severe complications have been observed in
patients with coronary artery or cerebrovascular disease
(Cashen et al., 2007).
We have nowdeveloped a straightforward strategy to produce
iPSCs from human cord blood (CB)-derived endothelial cells
(ECs) by means of lentiviral overexpression of OCT4, SOX2,
NANOG, and LIN28. Autologous and allogeneic human CB
represents a cell source that is, to date, routinely collected for
public and commercial blood banks.
Isolation of endothelial progenitors from CB is 10-fold more
efficient than from adult peripheral blood (Murohara et al.,
2000), and CB-derived cells have a significantly higher prolifera-
tion potential because of a higher telomerase activity (Ingram
et al., 2004). CB is expected to be superior to cells isolated
from aged individuals because nuclear and mitochondrial muta-
tions tend to accumulate in adult stem cells and differentiated
somatic lineages over an organism’s lifetime and have been
suggested to contribute to aging and cancer formation (Ono
et al., 2002; Trifunovic and Larsson, 2008). Whereas epigenetic
changes and loss of telomerase activity may be reversed in cells
of aging individuals during the induction of pluripotent stem cells
(Marion et al., 2009), acquired chromosomal abnormalities and/
or point mutations cannot be corrected during reprogramming
and are likely to influence the function of iPSC derivatives. More-
over, somatic cell clones with acquired mutations that result in
higher reprogramming efficiency and increased proliferation
rates may become selected over those with no mutations, and
thus enriched during expansion of the primary cell source. The
selection of such clones would be further enhanced during
reprogramming and proliferation of the resultant iPSCs, further
increasing the risk of cancer formation.
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establish human CB-derived iPSC (hCBiPSC) lines. In addition,
we demonstrated that the resultant hCBiPSCs can give rise to
functional cardiomyocytes and thus hold potential applicability
in cardiac cell therapies.
RESULTS AND DISCUSSION
Isolation of Cord-Blood-Derived Endothelial Cells
and Induction of Pluripotent Stem Cells
Recent reports suggest that the successful generation of human
iPSCs may be easier to achieve from adherent and actively
dividing cells than from nonadherent and slow-cycling cells.
Therefore, we sought to isolate a cell type that would be present
in CB in sufficient numbers and that could be easily obtained by
well-established and straightforward protocols. In addition, it
was crucial that the cells be adherent under standard culture
conditions and maintained proliferative ex vivo. Based on these
criteria, we tested cord-blood-derived endothelial cells (CBECs)
for the induction of pluripotent stem cells. In contrast to adult
peripheral blood (Rohde et al., 2007), high numbers of ECs
were obtained from CB. CBECs were isolated and cultivated
under EC culture conditions, yielding a monolayer of cells dis-
playing an EC cobblestone-like morphology. Individual isolates
of CBECs from different patients were compared. All CBEC
isolates showed high expression of endothelial markers (CD31,
CD146) and no expression of monocyte markers (CD45,
CD14), as determined by flow cytometry. After five passages,
a minor proportion of the cells were also CD34+ and CD133+,
which may reflect a progenitor cell origin (Figure S1A available
online). No remarkable differences in the expression of other
genes were found among different CBEC isolates by semiquan-
titative RT-PCR, confirming the above results (Figure S1B).
In addition, nonfractionated adult peripheral blood mononu-
clear cells (PBMCs) and/or monocytes isolated through adher-
ence on tissue-culture plates, along with primary lung fibroblasts
(LFs), were prepared.
To induce pluripotent stem cells, we transduced LFs, CBECs,
adult PBMCs, or monocytes with lentiviral vectors expressing
OCT4, SOX2, NANOG, and LIN28 (multiplicity of infection [MOI]
of 20 each) under the control of the hEF1a promoter. Control
transductions with a corresponding GFP-expressing vector with
similar MOIs resulted in 44% GFP+ CBECs (data not shown).
After 6 days in either fibroblast, endothelial, or PBMC culture
medium, cells were transferred to human embryonic stem cell
(hESC) culture conditions. After transduction, both PBMCs and
monocytes failed to proliferate. CBECs, however, did proliferate,
but the proliferation activity varied significantly among different
CBEC isolates (Figure 1A). Colonies of iPSCs were first observed
20–30 days after the transduction of LFs and CBECs.
Interestingly, our data suggest that the efficiency of reprog-
ramming correlates with proliferation activity: Reprogramming
experiments with adult, nonproliferative PBMCs or monocytes
did not lead to the formation of ESC-like colonies (Figure 1B;
Table S1). For CBECs, the reprogramming efficiency for the
individual slow-cycling isolates hCBEC939, hCBEC1024, and
hCBEC1197 was low, between 0.0001% and 0.0003%, resulting
in 1.66 ± 3.30 colonies/106 cells (Table S1; Figures 1A and 1B).
For hCBEC3 and hCBEC8 isolates, which had a significantlyaccelerated proliferation, reprogramming efficiency was consid-
erably higher, between 0.01% and 0.03%, resulting in 167.92 ±
104 colonies/106 cells (Table S1; Figures 1A and 1B). This effi-
ciency is similar to that previously found after the lentiviral trans-
duction of fibroblasts and keratinocytes (Maherali et al., 2008).
In order to identify the molecular basis of the varying prolifer-
ation capacity and reprogramming efficiency among individual
hCBEC isolates, we performed quantitative real-time RT-PCR
(qPCR) specific for the endogenous pluripotency genes OCT4,
SOX2, NANOG, LIN28, and MYC. As expected, minimal or no
expression of SOX2 and LIN28was detected, without significant
variation among individual isolates (Figure 1C). This was true also
for NANOG, with the exception of the hCBEC3 isolate, which
showed 500-fold lower expression than in human ESCs. For
OCT4, expression levels were 200- to 500-fold lower than
those in human ESCs. In contrast to the above factors, high
expression levels of endogenous MYC, 2.9- to 5.7-fold higher
than those in hESCs, were observed for all hCBEC isolates
(Figure 1D). Notably, no significant variations among individual
isolates were detected, suggesting that other cell cycle regula-
tors contribute to the high proliferation rate and reprogramming
efficiency of the hCBEC3 and hCBEC8 isolates. Eventually, we
cannot exclude the possibility that the reprogramming efficiency
for individualCBECisolatesdependsonthepresenceofaspecific
subpopulation, for instance with a progenitor-like phenotype.
However, at least for CD34+ cells, we did not observe a direct
correlation between a higher proportion of these cells and the
reprogrammingefficiencyforaspecificCBECisolate.
About 50% of the isolated primary colonies either did not
acquire a hESC-like appearance or could not be propagated
successfully. Some clones were lost because of cell differentia-
tion during further propagation. However, after two passages,
the remaining clones assumed a typical hESC-like morphology
(Figures S2A–S2F).
hLFiPSC and hCBiPSC Clones Show Typical
Characteristics of ESCs
For detailed characterization, eight hiPSC clones were cultured
and expanded under typical ESC conditions on murine embry-
onic fibroblasts (MEFs). Thus far, one human lung fibroblast-
derived iPSC (hLFiPSC) clone has been cultured for up to 71
passages, and hCBiPSC clones have been maintained for up
to 59 passages. Karyotype analyses revealed no abnormalities
in the hCBiPSC clones (passage 32), but trisomy of chromosome
20, which was not detected in the primary source LF, was
observed in the hLFiPSC clone in passage 30 (Figure S2G).
Southern blot analyses confirmed the independent origin of all
assayed iPSC clones. Individual cell clones contained one to
six or more copies of each transgene, with an average of 2.5
integrations of each vector per genome (Figure S2H, data not
shown for clones hCBiPSC7, 106, 109, 119, and 120).
hLFiPSCs and hCBiPSCs expressed the ESC markers OCT4,
SOX2, NANOG, LIN28, SSEA-3, SSEA-4, and TRA-1-60, as
demonstrated by immunocytology (Figure 2A). In the case of
hCBiPSCs, reprogramming led to the removal of the original
endothelial phenotype, as indicated by the loss of CD31 on
undifferentiated hCBiPSCs (Figure S3).
Expression levels of the transgenes were determined by qPCR
in undifferentiated cells of the eight iPSC clones (Figure 2B). TheCell Stem Cell 5, 434–441, October 2, 2009 ª2009 Elsevier Inc. 435
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Generation of Cord Blood iPSCsFigure 1. Reprogramming Efficiency in MYC-Expressing hCBEC Isolates Correlates with Individual Proliferation Rates
(A) Proliferation rates of different hCBEC isolates depicted as population doublings (PD)/day.
(B) Reprogramming efficiencies of hCBEC isolates, PBMCs, and monocytes.
(C) mRNA expression levels of endogenous OCT4, NANOG, SOX2, and LIN28 in hCBEC isolates and hESCs as determined by real-time PCR.
(D) MYC mRNA expression levels in different hCBEC isolates and hESCs as determined by qPCR.
Results are reported as mean ± SEM.degree of silencing variedbetweendifferent clones and individual
transgenes. Whereas the OCT4 transgene was still widely ex-
pressed at levels comparable to the endogenous gene expres-
sion, onlymoderateNANOG transgene expressionwas detected
in themajority of hCBiPSC clones. Furthermore, minimal expres-
sion of transgenic SOX2 and LIN28 was detected in most iPSC
clones (Figure 2B). Interestingly, in the hCBiPSC109 clone,
moderate to strong expression of all transgenes was observed.
As expected for iPSCs, induced expression of the endogenous
counterparts of all transgenes was considerably above the levels
detected in the source cells, LFs and CBECs. Although some
variation among clones was evident, endogenous expression
levels of OCT4, NANOG, SOX2, and LIN28 were similar to those
of hESCs (Figure 2C). Again, the hCBiPSC109 clone differed from
all other clones: minimal expression of endogenous OCT4 or
NANOG was observed and only SOX2 and LIN28 expression
was detected at high levels.
In order to elucidate the reprogramming status of iPSCs
generated from either LFs or CBECs, we next performed bisulfite
sequencing analysis on the OCT4 regulatory region. The OCT4436 Cell Stem Cell 5, 434–441, October 2, 2009 ª2009 Elsevier Inc.promoter in both somatic cell types, LFs and CBECs, was found
to be highly methylated. In contrast, the same region in the re-
programmed iPSCs was found to be significantly demethylated
(Figure 2D). Thus, our data strongly suggest that hLFiPSCs and
hCBiPSCs are properly reprogrammed, with an epigenetic
status similar to that of ESCs.
hCBiPSCs Differentiate into Derivatives of All Three
Germ Layers
To assess the cells’ in vitro differentiation capacity, we induced
the differentiation of hCBiPSCs and hESC controls into embryoid
bodies (EBs). Despite partially sustained transgene expression in
the hCBiPSCs, both clones that have been analyzed in more
detail (hCBiPSC1 and hCBiPSC2) differentiated well into deriva-
tives of all three germ layers. Interestingly, the substantial levels
of transgenic OCT4 and NANOG in undifferentiated hCBiPSCs
did not block the differentiation. In general, an increase in the
expression of all three germ layer markers was observed during
hCBiPSC differentiation, at levels comparable to hESCs (Fig-
ure S4).
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Generation of Cord Blood iPSCsFigure 2. Immunostaining for Typical ESC Markers, Partial Lentiviral Silencing, and Promoter Demethylation in hLFiPSCs and hCBiPSCs
(A) Typical ESC markers OCT4, NANOG, SSEA-4, SSEA-3, and Tra-1-60 (red) are shown for hCBiPSC clone 1 in passage 7. Nuclei are stained with DAPI (blue).
Scale bars represent 100 mm.
(B and C) The expression levels of transgenic (B) and endogenous (C) factors as quantified by qPCR are plotted relative to b-actin levels. Results are reported as
mean ± SEM.
(D) Bisulfite sequencing of the OCT4 promoter in hCBECs, hCBiPSCs, LFs, and LFiPSCs.Cell Stem Cell 5, 434–441, October 2, 2009 ª2009 Elsevier Inc. 437
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dermal] epithelium), AFP, Sox17, and HNF4 (endoderm), and
desmin as well as CD31 (mesoderm) were confirmed by immu-
nocytology (Figure 3A). Transplantation into immunodeficient
SCID-beige mice resulted in the formation of typical teratomas
containing derivatives of all three germ layers (Figures 3B–3E).
As expected, expression of endogenous OCT4, SOX2, and
NANOG decreased during the differentiation of hCBiPSC2
similar to hESCs (Figure 3F). During differentiation, endogenous
OCT4 expression in hCBiPSC2 decreased by a factor of 817
(hESCs: 102), SOX2 expression by a factor of 21 (hESCs: 6),
NANOG expression by a factor of 54 (hESCs: 97), and LIN28
expression by a factor of 15 (hESCs: 1.5). Interestingly, differen-
tiation of hCBiPSC2 in our EB-based protocol also led to a sus-
tained decrease in transgenic OCT4 expression, although by
a factor of only 7. It is likely that this decrease in transgenic
OCT4 does not represent the induction mechanism, but rather
appears to be a secondary effect of differentiation and might
actually reflect the typical silencing of the EF1a promoter during
differentiation (unpublished observations). Transgenic NANOG
expression, which was low, and transgenic SOX2 and LIN28
expression, which was very low, remained unchanged during
differentiation (Figure 3F).
Although immunocytology does not allow for the discrimina-
tion between transgene and endogenous protein expression, im-
munostaining specific for OCT4, SOX2, NANOG, and LIN28 was
performed (Figure S5). Consistent with the qPCR data, there was
a strong decrease of NANOG expression during differentiation,
with almost no NANOG+ cells detected on d17 of differentiation.
In contrast, and again consistent with the qPCR data, SOX2 and
LIN28 expression decreased considerably; however, SOX2+ and
LIN28+ cells were still frequently observed until d17 of differenti-
ation. This is in accordance with the fact that SOX2, as well as
LIN28, expression is known not to be restricted to pluripotent
stem cells. Despite a considerable decrease in OCT4 expres-
sion, many OCT4+ cells were still detected until d17 of differen-
tiation. This may indicate persistent transgene expression, as
demonstrated by qPCR.
Differentiation of hCBiPSCs and hESCs into
Spontaneously Contracting Cardiomyocytes
hCBiPSC1, hCBiPSC2, and hLFiPSCs were differentiated into
EBs. hLFiPSC and the assayed hCBiPSC clones differentiated
into spontaneously contracting cardiomyocytes (CMs) (Movie
S1). A more detailed analysis of the cardiac differentiation of
hCBiPSCs in comparison to hESCs was performed for the
hCBiPSC2 clone. Typically, beating areas first appeared on d9
of differentiation, and the proportion of spontaneously contract-
ing EBs increased up to 12%. Semiquantitative RT-PCR was
performed to characterize the cardiac differentiation over time
(Figure S4). A series of marker genes was included in the study:
Brachyury was selected as an early mesendodermal marker;
FOG2, NKX 2-5, TBX5, and TBX20 were included to follow
cardiac mesoderm induction; and MLC2a and aMHC served
as markers for maturing CMs. Albeit at low levels, most of the
analyzed markers could already be detected in ‘‘undifferenti-
ated’’ iPSCs and particularly in the cultures of the hESC line
HES-3 (Figure S4). Our conventional RT-PCR data suggest an
upregulation of all tested markers for mesoderm, cardiac meso-438 Cell Stem Cell 5, 434–441, October 2, 2009 ª2009 Elsevier Incderm, and CMduring differentiation. Increased expression of the
cardiac mesodermal marker genes NKX 2-5 and FOG2 in differ-
entiating iPSCswas first detected on d2 and d4 of differentiation.
The expression pattern of TBX5 and TBX20 in iPSC derivatives
was very similar to that of differentiating ESCs, with significant
transcript levels detected on d4. Considerable levels of aMHC
transcripts were also detected on d4. Figures 4A–4D show
well-organized cross-striations in iPSC-derived myocytes, as
demonstrated by immunostaining. Cells were positive for typical
sarcomeric proteins, such as sarcomeric a-actinin or cardiac
troponin T. The presence of the gap junction protein CX43 (con-
nexin 43) between iPSC-derived troponin T+ CMs (Figure 4D)
suggested functional coupling of these cells.
Patch Clamp Analyses Demonstrate the Presence
of Ventricular and Pacemaker-like hCBiPSC-Derived
CMs with a Functional b-Adrenergic Signaling Cascade
Patch clamp experiments were performed to further characterize
individual CMs after dissociation (Figures 4E–4G). iPSC-derived
CMs developed spontaneous electric activity, as indicated by
the typical cardiac extracellular FP shape and amplitude
(Figure 4E). We observed different types of action potentials
(APs): The left panel of Figure 4E depicts a ventricle-like AP
with fast upstroke velocity, a plateau phase, and large AP ampli-
tude, suggesting the contribution of both Ca2+ and Na+ channels
as the main depolarizing currents. The right panel shows an AP
morphology more reminiscent of pacemaker action potentials,
with a slower AP upstroke, no plateau phase, and smaller AP
amplitude. In Figure 4F, statistical analyses of action potentials
assigned to be either ventricle- or pacemaker-like, according
to the above-mentioned criteria, are shown. Finally, the sensi-
tivity of hCBiPS-CMs to the b-sympatomimetic drug isoproter-
enol was investigated to demonstrate a functional b-adrenergic
pathway at the single cell level. Isoproterenol led to an increase
in the spontaneous action potential frequency of hCBiPSC-CMs,
typical of its effect on cardiomyocytes (Figure 4G). Although
additional pharmacologic characterization is mandatory, our
present data already provide strong evidence for the similarity
of hCBiPSC2-CMs to both hESC-CMs and ventricular human
heart tissue.
Clearly, the use of CB as a ‘‘young’’ cell source with high bio-
logical quality for the generation of iPSCs sheds new light on
the customized collection and storage of autologous CB by
commercial CB banks. Until now, the usefulness of autologous
CB stem cells has been controversial, and their utility in the treat-
ment of genetically based diseases, such as many types of
leukemias, seems to be limited. In addition, there are issues of
restricted plasticity and ex vivo proliferative capacity (Hofmeister
et al., 2007). In contrast, CB is clearly useful for future therapeutic
production of juvenile iPSCs, providing a cell source that could
instantly be made available for thousands of pediatric patients,
which is of particular relevance for newborns with inherited
diseases and congenital malformations. Clinicians frequently
have evidence of these defects in utero, so CB samples have
been prospectively collected and stored in public CB banks
with the notion that suitable therapeutic options will become
available in the near future. In addition, HLA matching of alloge-
neic CB from public banks could be done, similar to current clin-
ical practice in the treatment of leukemia..
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Generation of Cord Blood iPSCsFigure 3. hCBiPSCs Differentiate into Ectodermal, Endodermal, andMesodermal Derivatives Both In Vitro and In Vivo Comparable to hESCs
(A) Immunostaining of hCBiPSC2 derivatives on d21 of differentiation revealed expression of ectodermal (b-tubulin, cytokeratin 18), endodermal (AFP, SOX17,
and HNF4), and mesodermal (CD31 and desmin) marker proteins (red). Nuclei are stained with DAPI (blue). Scale bars represent 100 mm.
(B–E) Injection of undifferentiated hCBiPSCs into immunodeficient SCID-beige mice led to formation of teratomas containing derivatives of all three germ layers.
(B) Two areas of chondrocytes representing mesoderm formation.
(C) Immature neuronal tissue showing a large number of mitotic figures, representing early formation of neural tube-like structures.
(D) Beginning keratinization of a cell, as indicated by basophil-reacting keratohyalin granula in the cytoplasm, surrounded by sebaceous gland-like structures,
likely representing ectodermal differentiation.
(E) Endodermal epithelium with prominent mucus-producing cells and muscle tissue representing endoderm and mesoderm formation. Scale bars represent 50
or 100 mm as depicted.
(F) qPCR was performed to follow the expression of endogenous and transgenic pluripotency-related factors during differentiation. Results are reported as
mean ± SEM.Cell Stem Cell 5, 434–441, October 2, 2009 ª2009 Elsevier Inc. 439
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Generation of Cord Blood iPSCsFigure 4. Detection of Typical CM Proteins in hCBiPSC2 Derivatives by Immunofluorescence Staining on Day 21 of Differentiation and Patch
Clamp Analyses of Individual Cardiomyocytes
(A–D) Cells were stained with antisarcomeric a-actinin (red, A, B), anticardiac troponin T (red, C, D), and anti-CX43 (green, D). Nuclei are stained with DAPI (blue).
Scale bars represent 100 mm.
(E–G) Results of patch clamp analyses of individual cardiomyocytes.
(E) Original traces of typical action potentials.
(F) Mean data for action potential amplitude (AP amplitude), maximal AP upstroke velocity (Vmax), maximum diastolic potential (MDP), and action potential dura-
tion measured at 90% or 50% repolarization (APD 90 or 50) assigned to be either ventricle- or pacemaker-like according to the above-mentioned criteria.
(G) Original trace at baseline (left) and upon addition of isoproterenol (Iso, 1 mM) (right). The addition of isoproterenol increased the spontaneous action potential
frequency by 50%. Results are reported as mean ± SEM.In conclusion, we have identified CB as a novel cell source for
the derivation of iPSCs. Our study provides a feasible strategy for
the reproducible generation of induced pluripotent stem cells
from human cord blood. In view of the questionable quality of
cells of aging individuals, allogeneic and autologous CB from
public and commercial CB banks may provide a superior and
almost unlimited juvenescent cell source for the production of
clinically useful iPSCs. In addition, we were able to demonstrate
the differentiation of human CBiPSCs into functional cardiomyo-
cytes. Our results therefore establish an important basis for the440 Cell Stem Cell 5, 434–441, October 2, 2009 ª2009 Elsevier Incdevelopment of iPSC-based therapies with high relevance for
the treatment of pediatric patients.
EXPERIMENTAL PROCEDURES
Preparation of Lentiviral Vector Stocks
Plasmids pSIN-EF2-Oct-Pur, pSIN-EF2-Sox2-Pur, pSIN-EF2-Nanog-Pur, and
pSIN-EF2-LIN28-Pur were obtained from Addgene (http://www.addgene.org).
Viruses were produced, concentrated, and titered according to standard
procedures..
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Human LFs were isolated from pulmonary resections and cultured under stan-
dard conditions. Written informed consent was obtained from all tissue donors
according to the legal requirements. Mononuclear cells were isolated from
heparinized human peripheral and cord blood through Ficoll density gradient
centrifugation. For preparation of hCBECs or monocytes, either CD34+ cells
recovered by immunomagnetic separation or whole mononuclear cells were
enriched via plastic adherence. Human umbilical CB had been obtained
from healthy newborn donors after informed parental consent.
Induction of Pluripotent Stem Cells
Cells were transduced with concentrated lentiviral vectors (MOI 20 each) in
fibroblast or endothelial culture medium containing 8 mg/ml polybrene as
described previously (Takahashi et al., 2007) with slight modifications.
Culture of Undifferentiated Human iPSCs and ESCs
ESCs and iPSCs were cultured and expanded under standard hESC culture
conditions.
Differentiation of Human ESCs and iPSCs
For EB-based differentiation, human ESCs/iPSCs were dispersed into small
clumps and cultured in differentiation medium (80% IMDM supplemented
with 20% fetal calf serum) in ultra-low attachment plates for 7 days. Subse-
quently, EBs were plated onto gelatin-coated tissue culture dishes.
Teratomas were induced by injection of the cell suspension under the renal
capsule or into a hind limb muscle of SCID-beige mice. After 8–10 weeks, the
animals were sacrificed. During all experiments, the ‘‘Principles of laboratory
animal care’’ (NIH publication No. 86-23, revised 1985) as well as the Animal
Welfare Law of Lower Saxony were followed.
Analysis ofmRNAExpression byRT-PCRandQuantitative Real-Time
PCR
Total RNA was prepared with the RNeasy Kit (Macherey-Nagel) and reverse
transcribed with Superscript II by means of oligo dT primers according to
manufacturer’s instructions. PCR and qPCR were performed as previously
described (Mauritz et al., 2008). Sequences and specifications of primers
are shown in Tables S2 and S3. Data are given as mean ± SEM of normalized
gene expression levels from three differentiation experiments.
Immunocytological Staining
Immunostaining was performed according to standard protocols. Primary
antibodies that were used are described in Table S4.
Bisulfite Sequencing Analysis
Bisulfite sequencing was performed with the EpiTect Bisulfite Kit (QIAGEN)
according to manufacturer’s protocol. PCR products were subcloned with
the PCR 2.1-TOPO vector (Invitrogen) and individual clones were sequenced.
Clones with at least 90% cytosine conversion were accepted, and all possible
clonalities were excluded based on criteria from the BiQ Analyzer software. At
least 10 replicates were performed for each of the selected regions.
Patch Clamp Experiments
Action potentials were measured with the whole-cell patch clamp technique in
a cell-attached configuration with a current clamp as previously reported
(Guan et al., 2007).
Statistical Analysis
Results are reported as mean ± SEM. Values with p < 0.05 were considered to
be statistically significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, five
figures, four tables, and one movie and can be found with this article online
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